Xin Zhao

ORCID: 0000-0003-0502-5007
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Lung Cancer Treatments and Mutations
  • Pancreatic and Hepatic Oncology Research
  • Cytokine Signaling Pathways and Interactions
  • Cancer Immunotherapy and Biomarkers
  • Liver Disease Diagnosis and Treatment
  • Fungal Biology and Applications
  • Genetics and Neurodevelopmental Disorders
  • Cancer Mechanisms and Therapy
  • Gaze Tracking and Assistive Technology
  • Cancer Treatment and Pharmacology
  • Nutrition and Health in Aging
  • Silymarin and Mushroom Poisoning
  • Neuroendocrine Tumor Research Advances
  • Growth Hormone and Insulin-like Growth Factors
  • ATP Synthase and ATPases Research
  • Protein Tyrosine Phosphatases
  • Hearing Loss and Rehabilitation
  • Cancer therapeutics and mechanisms
  • Colorectal Cancer Treatments and Studies
  • interferon and immune responses
  • Endometrial and Cervical Cancer Treatments
  • Ear and Head Tumors
  • Reading and Literacy Development
  • Cancer Genomics and Diagnostics

Hebei Medical University
2011-2025

Zhengzhou University
2024

People's Hospital of Bishan District
2023-2024

Third Affiliated Hospital of Zhengzhou University
2013-2024

Leshan Normal University
2021

University of Copenhagen
2019

Tianjin Medical University
2017

Sichuan Cancer Hospital
2013

Chengdu Third People's Hospital
2013

First Affiliated Hospital of Hebei Medical University
2011

Abstract Since children with autism spectrum disorder (ASD) might exhibit a variety of aberrant response to joint attention (RJA) behaviors, there is growing interest in identifying robust, reliable and valid eye‐tracking metrics for determining differences RJA behaviors between typically developing (TD) those ASD. Previous studies have not been deeply investigated nonlinear features gaze time‐series during RJA. As main motivation, this study aimed extract three (i.e., complexity, long‐range...

10.1002/aur.3000 article EN Autism Research 2023-08-02

Background Gefitinib is widely used in patients with advanced non-small-cell lung cancer (NSCLC), whom chemotherapy had failed. Previous trials reported inconsistent findings regarding the efficacy of gefitinib on overall survival (OS) and progression free (PFS). This study was to evaluate effects plus versus alone NSCLC. Methods We systematically searched Medline, EmBase, Cochrane Central Register Controlled Trials, reference lists articles, proceedings major meetings for relevant...

10.3760/cma.j.issn.0366-6999.20122920 article EN cc-by-nc-nd Chinese Medical Journal 2013-09-05

Aim: This study aimed to investigate the prognostic value of peripheral naive and memory CD8+ CD4+ T cells other immune in patients with oligometastatic non-small-cell lung cancer (NSCLC) undergoing radiotherapy (RT). Methods: A total 142 NSCLC treated RT were enrolled, their blood samples collected within 3 days before RT. Immune identified by flow cytometry. Results: Patients high levels had longer overall survival (p = 0.004) progression-free 0.001) than those low cells. Multivariate...

10.2217/fon-2021-0728 article EN Future Oncology 2021-10-05

The objective of this investigation was to ascertain the effectiveness an ultrasound-guided erector spinae plane block (ESPB) administered patients diagnosed with hepatocellular carcinoma who were subjected laparoscopic left hemihepatectomy.

10.1097/sle.0000000000001344 article EN Surgical Laparoscopy Endoscopy & Percutaneous Techniques 2024-11-21

<title>Abstract</title> <bold>Background:</bold> Although the treatment of lung cancer has been well developed, survival rate for squamous cell carcinoma (LUSC) is still low. It meaningful to explore new molecular targets and develop strategies. SH3RF2 an E3 ubiquitin ligase containing 3 SH3 domains not reported in LUSC. <bold>Results: </bold>SH3RF2 promoted proliferation LUSC cells, nuclear translocation β-catenin, increased Arg-1, CD163 IL-10 RNA levels proportion CD206+ cells M0 THP-1...

10.21203/rs.3.rs-5457209/v1 preprint EN cc-by Research Square (Research Square) 2024-12-03

Objective To investigate the relationship between age and cochlear height (CH) value.Methods From 2006 to 2012,213 patients aged 1 month 21 years were chose,temporal bone coronal CT scan was performed for 426 ears,CH value measured by high resolution ratio CT.The CH differences different ages,sexes hearing loss types compared.The of the15 at groups analyzed.Results The average (4.29 ± 0.45) mm in patients,(4.32 0.43) males,(4.26 0.48)mm females,the slightly higher males than that...

10.3760/cma.j.issn.1674-4756.2014.07.021 article EN Central Plains Medical Journal 2014-04-10

Zhao, Xin MM; Mao, Tianyang Xie, Qingyun Gao, Fengwei MD; Wu, Hong MD Author Information

10.1097/js9.0000000000000891 article TL cc-by-nc-nd International Journal of Surgery 2023-11-17

Objective To investigate the biological function of IFN-λ in 7 human esophageal carcinoma cells. Methods The gene expression IL-28α, IL-10β and antiviral molecule was examined with PCR. MHC molecules profiles cell cycle were analyzed flow cytometer. Cell proliferation evaluated MTT assay. Results All cells express II-28α IL-10β. induced or augmented molecules, 2′5′-OAS MxA. enhanced class Ⅰ expression. inhibited growth through regulation distribution. Conclusion Esophageal receptor complex....

10.3760/cma.j.issn.0254-5101.2011.08.007 article EN Zhonghua weishengwuxue he mianyixue zazhi 2011-08-31

e20044 Background: As the rapidly increasing of potential anti-cancer agents, it has significantly improved clinical outcomes non-small cell lung cancer (NSCLC). However, been challenged by accurately characterize genome changes which link to response specific targeted therapeutics. This umbrella study aimed provide real-world data on efficacy therapies multiple gene sequencing in NSCLC Chinese population and explore for implementation personalized therapy practice. Methods: consists five...

10.1200/jco.2019.37.15_suppl.e20044 article EN Journal of Clinical Oncology 2019-05-20

The International Federation of Gynecology and Obstetrics (FIGO) stage remains the standard staging system for assessment endometrial cancer (EC) prognosis. Thus, we aim to identify significant genes or biomarkers associated with cancer, which may also help reveal mechanism EC progression assess prognosis patients EC.We compared mRNA expression levels stages I II as well III IV in Cancer Genome Atlas (TCGA) database. differentially expressed (DEGs) at different were selected by volcano plot...

10.1371/journal.pone.0262000 article EN cc-by PLoS ONE 2022-01-25
Coming Soon ...